Tailoring access to high cost, genetically targeted drugs

Area of Science:

• Health Economics
• Biostatistics
• Data Privacy

Background:

• Linking financial data to individual health outcomes is crucial for accurate cost-effectiveness analysis.
• Protecting patient privacy during data linkage presents significant ethical and technical challenges.
• Current methods often struggle to balance data utility with robust privacy safeguards.

Discussion:

• Discussing the methodologies for integrating real-world cost data with longitudinal health outcomes.
• Exploring the ethical considerations and regulatory frameworks surrounding sensitive health data.
• Analyzing the technical approaches to anonymize or pseudonymize data for linkage.

Key Insights:

• Real cost-effectiveness assessment demands innovative data linkage strategies.
• Patient privacy protection is paramount and requires advanced security measures.
• Effective solutions must demonstrate a clear link between expenditure and health results.

Outlook:

• Future research should focus on developing privacy-preserving analytical techniques.
• Advancements in secure data enclaves and federated learning can facilitate this linkage.
• This will enable more precise health economic evaluations and resource allocation.